These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 15824469)
1. Effects of bradykinin on cardiovascular remodeling in renovascular hypertensive rats. Tanaka Y; Nagai M; Date T; Okada T; Abe Y; Seki S; Taniguchi M; Taniguchi I; Mochizuki S Hypertens Res; 2004 Nov; 27(11):865-75. PubMed ID: 15824469 [TBL] [Abstract][Full Text] [Related]
2. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis. Takemoto M; Egashira K; Tomita H; Usui M; Okamoto H; Kitabatake A; Shimokawa H; Sueishi K; Takeshita A Hypertension; 1997 Dec; 30(6):1621-7. PubMed ID: 9403592 [TBL] [Abstract][Full Text] [Related]
3. Discoordinate re-expression of cardiac fetal genes in N(omega)-nitro-L-arginine methyl ester (L-NAME) hypertension. Zhang Y; Carreras D; de Bold AJ Cardiovasc Res; 2003 Jan; 57(1):158-67. PubMed ID: 12504825 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats. Nakamura Y; Ono H; Zhou X; Frohlich ED Hypertension; 2001 May; 37(5):1262-7. PubMed ID: 11358938 [TBL] [Abstract][Full Text] [Related]
5. N(G)-nitro-L-arginine methyl ester-induced hypertension and natriuretic peptide gene expression: inhibition by angiotensin II type 1 receptor antagonism. Suo M; Kalliovalkama J; Pörsti I; Jolma P; Tolvanen JP; Vuolteenaho O; Ruskoaho H J Cardiovasc Pharmacol; 2002 Sep; 40(3):478-86. PubMed ID: 12198334 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II-induced myocardial fibrosis in rats: role of nitric oxide, prostaglandins and bradykinin. Sigusch HH; Campbell SE; Weber KT Cardiovasc Res; 1996 Apr; 31(4):546-54. PubMed ID: 8689646 [TBL] [Abstract][Full Text] [Related]
7. Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis. Pacca SR; de Azevedo AP; De Oliveira CF; De Luca IM; De Nucci G; Antunes E J Cardiovasc Pharmacol; 2002 Feb; 39(2):201-7. PubMed ID: 11791005 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975 [TBL] [Abstract][Full Text] [Related]
9. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats. Resende AC; Pimentel AM; de Moura RS Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):756-61. PubMed ID: 15566389 [TBL] [Abstract][Full Text] [Related]
10. Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor. de Oliveira CF; Cintra KA; Teixeira SA; De Luca IM; Antunes E; De Nucci G Eur J Pharmacol; 2000 Mar; 391(1-2):121-6. PubMed ID: 10720643 [TBL] [Abstract][Full Text] [Related]
11. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats. Sanada S; Kitakaze M; Node K; Takashima S; Ogai A; Asanuma H; Sakata Y; Asakura M; Ogita H; Liao Y; Fukushima T; Yamada J; Minamino T; Kuzuya T; Hori M Hypertension; 2001 Sep; 38(3):404-11. PubMed ID: 11566913 [TBL] [Abstract][Full Text] [Related]
12. Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension. Simko F; Matuskova J; Luptak I; Krajcirovicova K; Kucharska J; Gvozdjakova A; Babal P; Pechanova O Life Sci; 2004 Jan; 74(10):1211-24. PubMed ID: 14697405 [TBL] [Abstract][Full Text] [Related]
13. Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy. Rossi MA; Ramos SG; Prado CM J Hypertens; 2003 May; 21(5):993-1001. PubMed ID: 12714875 [TBL] [Abstract][Full Text] [Related]
14. Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats. Amann K; Gassmann P; Buzello M; Orth SR; Törnig J; Gross ML; Magener A; Mall G; Ritz E Kidney Int; 2000 Jul; 58(1):153-61. PubMed ID: 10886560 [TBL] [Abstract][Full Text] [Related]
15. Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat. Khattab MM; Mostafa A; Al-Shabanah O Kidney Blood Press Res; 2005; 28(4):243-50. PubMed ID: 16220007 [TBL] [Abstract][Full Text] [Related]
16. Effect of imidapril on myocardial remodeling in L-NAME-induced hypertensive rats is associated with gene expression of NOS and ACE mRNA. Kobayashi N; Hara K; Watanabe S; Higashi T; Matsuoka H Am J Hypertens; 2000 Feb; 13(2):199-207. PubMed ID: 10701821 [TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition. Kaikita K; Fogo AB; Ma L; Schoenhard JA; Brown NJ; Vaughan DE Circulation; 2001 Aug; 104(7):839-44. PubMed ID: 11502712 [TBL] [Abstract][Full Text] [Related]
18. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice. Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat. Wollert KC; Studer R; Doerfer K; Schieffer E; Holubarsch C; Just H; Drexler H Circulation; 1997 Apr; 95(7):1910-7. PubMed ID: 9107180 [TBL] [Abstract][Full Text] [Related]
20. Renoprotective effects of captopril in hypertension induced by nitric oxide synthase inhibition in experimental nephritis. Uhlenius N; Tikkanen T; Miettinen A; Holthöfer H; Törnroth T; Eriksson A; Fyhrquist F; Tikkanen I Nephron; 1999 Feb; 81(2):221-9. PubMed ID: 9933759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]